Background
Metformin is widely used for the treatment of type‐2 diabetes (T2D) but was shown to cause vitamin‐B12 deficiency. H pylori infection was also suggested to cause vitamin‐B12 deficiency. This study aimed to elucidate the relationships in this triad by investigating vitamin‐B12 deficiency and H pylori infection in T2D patients using metformin.
Materials and Methods
This descriptive cross‐sectional study recruited T2D patients using metformin from a primary care center and examined their socioeconomic status, accompanying complaints, medication use, and hemogram parameters such as serum vitamin B12, calcium, and hemoglobin. The presence of H pylori infection was determined through stool antigen test.
Results
Study included 421 T2D patients on metformin regimen: 213 (50.6%) males and 208 (49.4%) females. The mean duration of diabetes was 9.88 ± 7.32 years, and the total metformin dose was 1925.5 ± 236.7 mg/d. Almost half of the participants (n = 199, 47.3%) had H pylori infection, and more than half (n = 222, 52.7%) had vitamin‐B12 deficiency. The rate of vitamin‐B12 deficiency was significantly higher among those with H pylori infection. No significant relationship was found between the daily metformin dose and vitamin‐B12 deficiency.
Conclusions
This study supported the role of H pylori infection in vitamin‐B12 deficiency. However, the effects of increased metformin dose and H pylori infection on vitamin‐B12 levels were not additive. It is recommended that vitamin‐B12 levels in T2D patients are monitored and those with vitamin‐B12 deficiency, regardless of metformin dose, are screened for H pylori and, if necessary, treated.